Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2026-01-08 @ 6:53 AM
Study NCT ID:
NCT00460460
Status:
TERMINATED
Last Update Posted:
2011-01-25
First Post:
2007-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |